burn - Nursing Case Study
Pathophysiology
• Primary mechanism: Burns cause direct tissue damage, leading to cell membrane disruption, protein denaturation, and loss of skin integrity, which initiates an inflammatory response. This results in increased vascular permeability and fluid loss, contributing to edema and hypovolemia.
• Secondary mechanism: The intense inflammatory response triggers the release of cytokines and inflammatory mediators, which can lead to systemic inflammatory response syndrome (SIRS) and potential multi-organ dysfunction if not managed promptly.
• Key complication: Hypovolemic shock due to significant fluid and plasma loss is a critical concern, necessitating aggressive fluid resuscitation to maintain hemodynamic stability and prevent organ failure.
Patient Profile
Demographics:
32-year-old male, construction worker
History:
• Key past medical history: Hypertension, smoker for 10 years
• Current medications: Lisinopril 10 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe burn on the right arm and chest
• Key symptoms: Blistering and redness on the right arm and chest, increasing pain, signs of infection (red streaks, warmth, and swelling), fever
• Vital signs: Temperature 101.5°F, Heart rate 112 bpm, Blood pressure 138/92 mmHg, Respiratory rate 22 breaths per minute
Section 1
As the healthcare team continues to monitor the patient, new complications arise, indicating an evolution in his condition. The patient begins to exhibit signs consistent with evolving sepsis secondary to the burn infection. His vital signs show further deviations from normal: his temperature spikes to 102.8°F, heart rate increases to 128 bpm, and his blood pressure drops to 120/80 mmHg, suggesting a developing distributive shock. The patient's respiratory rate remains elevated at 24 breaths per minute, and he reports increasing confusion and lethargy, raising concerns about potential systemic involvement.
Laboratory results confirm a rising white blood cell count of 18,000/mm³, suggesting a heightened inflammatory response. Blood cultures are pending, but the clinical suspicion for bacteremia is high due to the presence of red streaks and localized warmth spreading from the burn site. Additionally, the patient's lactate level is elevated at 3.5 mmol/L, indicating tissue hypoperfusion and corroborating the clinical picture of sepsis. Despite aggressive fluid resuscitation, the patient maintains signs of hypoperfusion, necessitating the consideration of vasopressor support to maintain adequate blood pressure and end-organ perfusion.
In response to these developments, the healthcare team initiates broad-spectrum intravenous antibiotics, mindful of the patient's penicillin allergy, opting for a combination of vancomycin and meropenem. The patient is closely monitored for any adverse reactions to the antibiotics and for any further changes in his hemodynamic status. Critical care involvement is considered to provide advanced monitoring and potential interventions such as central venous access for more precise fluid and medication administration. The team strategizes on optimizing the patient's fluid management and continues to assess for indications of organ dysfunction, preparing for potential escalation of care should his condition not improve.
Section 2
As the healthcare team continues to monitor the patient, his condition exhibits a concerning change. Despite the initiation of broad-spectrum antibiotics and fluid resuscitation, his clinical status shows signs of deterioration. The patient is now exhibiting increased respiratory distress, with his respiratory rate climbing to 30 breaths per minute and oxygen saturation dropping to 88% on room air, necessitating supplemental oxygen via nasal cannula. His confusion has progressed to periods of disorientation, and he is less responsive to verbal stimuli, indicating worsening neurological status that raises concerns for potential septic encephalopathy.
A repeat assessment of the burn wound reveals further progression of infection, with increased purulence and expanding erythema. The surrounding tissue appears more edematous, and the red streaking has extended, suggesting lymphangitic spread. Given these findings, the suspicion for systemic infection remains high, and the blood cultures subsequently return positive for gram-negative bacilli, necessitating a potential reevaluation of the antibiotic regimen to ensure appropriate coverage.
The patient's hemodynamic profile is equally alarming. His blood pressure has decreased further to 110/70 mmHg despite fluid resuscitation, and his heart rate remains elevated at 130 bpm, suggesting ongoing distributive shock. The decision is made to initiate vasopressor support with norepinephrine to stabilize his blood pressure and ensure adequate perfusion to vital organs. Concurrently, consultations with critical care and infectious disease specialists are expedited to refine the management plan, with a focus on addressing the persistent infection and optimizing the patient's hemodynamic stability and respiratory support. The interdisciplinary approach aims to avert further deterioration and guide the patient toward recovery, taking into account the evolving complexities of his condition.
Section 3
As the healthcare team continues to manage the patient's complex condition, a new complication emerges, demanding immediate attention and further clinical reasoning. Despite the initiation of norepinephrine and supplemental oxygen, the patient's respiratory status continues to decline. He develops acute respiratory distress, characterized by an increased work of breathing, accessory muscle use, and a further drop in oxygen saturation to 84% even with 4 liters of oxygen via nasal cannula. The decision is made to escalate respiratory support to high-flow nasal cannula therapy, which slightly improves his oxygenation but fails to fully stabilize his respiratory status.
A chest X-ray is ordered to investigate the cause of the escalating respiratory distress, revealing bilateral infiltrates suggestive of acute respiratory distress syndrome (ARDS), a complication potentially secondary to sepsis. The development of ARDS introduces a new layer of complexity to the patient's care, necessitating a multidisciplinary approach to manage both the respiratory failure and the underlying infection. The critical care team considers the potential need for mechanical ventilation if the patient's respiratory effort does not improve.
Lab results show a significant increase in inflammatory markers, with a C-reactive protein level of 180 mg/L and a procalcitonin level markedly elevated at 15 ng/mL, confirming the suspicion of severe systemic infection. The infectious disease team reviews the antibiotic regimen, discussing the need for broadening coverage to include resistant gram-negative organisms given the blood culture results. The focus now shifts to aggressive management of the evolving respiratory failure while continuing to address the underlying sepsis, requiring close monitoring of the patient's hemodynamic status and organ function as the team works to prevent further deterioration and guide him toward stabilization.
Section 4
As the healthcare team continues to manage the patient's condition, a new complication arises, further challenging their clinical reasoning and decision-making skills. Despite aggressive interventions to manage the ARDS and sepsis, the patient's renal function begins to decline, evidenced by a sudden increase in serum creatinine to 2.3 mg/dL from a baseline of 0.9 mg/dL, and a corresponding decrease in urine output to less than 0.5 mL/kg/hr over the past six hours. This development of acute kidney injury (AKI) adds a critical layer of complexity to his care, necessitating immediate adjustments in fluid management and consideration for renal replacement therapy if renal function continues to deteriorate.
The nephrology team is consulted to evaluate the patient's renal status and to provide guidance on optimizing fluid balance while avoiding volume overload, which could exacerbate the ARDS. They recommend cautious diuretic use to manage fluid status and prevent further strain on the heart and lungs. Concurrently, the critical care team must carefully titrate vasopressors to maintain adequate perfusion pressure without compromising renal blood flow. Daily monitoring of kidney function tests, electrolytes, and fluid balance becomes paramount in guiding treatment adjustments.
With the emergence of AKI, the patient’s metabolic status is closely monitored for signs of metabolic acidosis, which could further complicate his clinical picture. The healthcare team emphasizes the importance of multidisciplinary collaboration, integrating insights from nephrology, critical care, and infectious disease specialists to navigate this multifaceted case. While the patient's condition remains precarious, the team's proactive approach and comprehensive management plan aim to stabilize his organ function and prevent further complications, setting the stage for the next phase of his recovery.
Section 5
As the healthcare team continues to manage the patient's condition, new diagnostic results reveal concerning changes in his metabolic status. Arterial blood gas analysis indicates the development of metabolic acidosis, with a pH of 7.31, bicarbonate level of 18 mEq/L, and a base deficit of -6. This finding suggests an increased anion gap, likely due to the accumulation of toxins that the compromised kidneys are unable to excrete effectively. Serum lactate levels are also elevated at 3.5 mmol/L, indicating ongoing tissue hypoperfusion and possible worsening of sepsis. These results prompt the team to reassess their current treatment plan, focusing on correcting the acid-base imbalance while continuing to support the patient's renal and respiratory systems.
In response to the metabolic acidosis, the critical care team initiates a careful titration of intravenous bicarbonate to address the acid-base disturbance, while ensuring that the correction does not lead to fluid overload. The nephrology team emphasizes the importance of maintaining an optimal fluid balance, suggesting the use of continuous renal replacement therapy (CRRT) as a potential intervention to manage both the patient's fluid status and his metabolic derangements. This approach is considered, especially if there is no improvement in renal function and the acidosis persists despite initial measures.
The interdisciplinary team continues to monitor the patient's response to these interventions closely, with serial assessments of vital signs, urine output, and laboratory values. The patient's blood pressure remains stable with the cautious use of vasopressors, maintaining a mean arterial pressure of 65-70 mmHg. However, the team remains vigilant for any signs of further deterioration, such as increased respiratory distress or hemodynamic instability, which would require immediate escalation of care. By maintaining a dynamic and collaborative approach, the team aims to stabilize the patient's condition and facilitate a gradual recovery, preparing for the subsequent phases of his treatment journey.